SIRPA and brain neoplasm: While we have previously shown that blocking the myeloid checkpoint CD47-SIRPα axis is efficacious against multiple adult and pediatric brain tumors, the specific role of microglia in anti-CD47 treatment remains unclear (9, 10, 17, 18).